The proposed algorithms for pasireotide-induced hyperglycemia treatment are based mainly on current recommendations for T2DM therapy, a few clinical studies available for CD and acromegaly, and clinical practice
You get exactly what you pay for
Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials
Fineman M, Flanagan S, Taylor K, Aisporna M, Shen LZ, Mace KF, et al
is a wholly owned subsidiary of Enzo Biochem, Inc
Adults with overweight or obesity newly prescribed liraglutide (Victoza/Saxenda, Novo Nordisk), subcutaneous semaglutide (Ozempic/Wegovy, Novo Nordisk) or tirzepatide (Mounjaro/Zepbound, Eli Lilly) from 2018 to 2023 were included
